Burkholderia cepacia contamination is a risk for drug makers according to the US FDA, which says only rigorous testing can ensure the safety of non-sterile, water-based products.
Lack of funding is threatening development of a nasal spray vaccine shown to provide long-term protection for non-human primates against the Ebola virus, the lead researcher told this publication in an exclusive interview.
The World Health Organisation says a meeting between drugmakers and high-level government representatives last week has yielded plans to fast-track scale-up of Ebola vaccines in the face of incomplete trials and leaked production problems.
As the death toll from the world’s most expansive Ebola outbreak nears 1,000, multiple companies are stepping up efforts to bring antibodies and other vaccines to human trials, though none seem likely to be ready until 2015 at the earliest.
The worst Ebola virus outbreak in history continues to spread in West Africa as biopharma companies are hampered by funding issues in trying to bring treatments and vaccines to human trials, a scientist says.
French CMO Indicia production says the acquisition of Biotechnologie Appliquee will strengthen its ready-to-use media manufacturing and add R&D capabilities to its offerings.
PPD has expanded its central lab testing services at its Brussels and Singapore labs and will offer additional services in microbiology, peripheral blood mononuclear cell and molecular pathology services.
Taiwan’s efforts to position itself as a major biotechnology hub received a further boost today with the opening of Merck KGaA’s dedicated technology training centre in Xizhi City, Taipei County.
bioMerieux hopes that its new specially-packaged growth media products will help it “clean up” in the pharmaceutical industry’s lucrative sterility testing market
A new, freely available database has been launched that provides
comprehensive information about the 600 known bacteria living in
the human mouth. Many of these bacteria also cause infections
in the lungs, blood and skin, so the...
Oxoid has introduced a new plate design for the Oxoid range of
Contact Plates, which aims to make the microbiological testing of
surfaces even easier to store, handle and use.
Danish biotechnology firm Novozymes has acquired Delta
Biotechnology from sanofi-aventis, looking to strengthen its
bioprocessing expertise in enzymes and microorganisms with Delta's
ability to manufacture recombinant proteins...
After receiving a grant of $3.9m (€3m) from the US government,
British biotechnology firm Avecia has put together a consortium of
four companies to develop a version of its anthrax vaccine with
increased stability so it works without...
The European Medicines Agency (EMEA) has given Sanofi Pasteur the
green light to market a childhood vaccine containing Delta's
Recombumin, a recombinant human albumin which offers the world's
first and only animal-free alternative...
US-based Nabi Biopharmaceuticals has secured an exclusive supply
and contract manufacturing deal with French-based vaccines giant
Sanofi Pasteur to streamline the production of its rabies vaccine.
UK's Biotrace has signed a deal giving US company Pall Corporation
exclusive global marketing and distribution rights to its range of
microbiological air monitoring products for the pharma industry in
order to broaden the geographic...
Filtration specialists, Pall, and Biotrace have signed an agreement
to market microbiological air monitoring technology to the
pharmaceutical industry. The deal focuses on microbiological
monitoring of manufacturing processes, which...
Greenbridge Environmental Control of the UK has introdueced a new
cleaner and disinfectant agent, suitable for commercial scale
applications, that is claimed to be the first non-toxic product of
its type.
Celsis International has signed a collaboration with BioVentures to
develop a microarray-based microbiological testing system to detect
contamination in pharmaceutical, biotechnology and other process
industries.
Biotrace of the UK has acquired MicroSafe Group, an Italian
supplier of microbiological testing products for the
pharmaceutical, food and defence sectors, for £2.5 million.
A new approach to prevent infection of West Nile and dengue fever
may be on the horizon after a US team identified interactions
involving the alfalfa mosaic virus (AMV). The virus is a close
relative of the flaviviruses that cause...
Separation and filtration specialist Millipore has launched an
automated system for the rapid detection, response and resolution
of microbial contamination in manufacturing processes.
GlaxoSmithKline has secured rights to a technology, developed in
partnership with US company Advaxis, could improve the
effectiveness of vaccine-based treatments for cancer.
Dutch biotechnology company Crucell has announced a new project
aimed at developing a vaccine for West Nile virus, a flu-like
illness that can cause a brain infection with a mortality rate of 1
per cent
Strasbourg, France-based Aventis has signed a research, option and
license agreement with Vivalis of the USA for the manufacture of
vaccine candidates using avian stem cell technology.
